Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1625 1634 1691
This examiner grants 78% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18291630 | PHOSPHATE PRODRUGS OF CANNABINOIDS | Non-Final OA | Emory University |
| 18674715 | SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 | Non-Final OA | Massachusetts Institute of Technology |
| 18566008 | COMPOSITIONS OF CLOFAZIMINE AND AMIKACIN FOR PULMONARY ADMINISTRATION IN THE TREATMENT OF RESPIRATORY DISEASES | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18722233 | COMBINATION OF AN A2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA | Non-Final OA | BAYER AKTIENGESELLSCHAFT |
| 18419894 | ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF | Non-Final OA | Celgene Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy